Ин се технологияи саломатии ҳоҷатхонаҳо дар ИМА аз ҷиҳати клиникӣ санҷида мешаванд, Исроил ва Япония
Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 июн. The technology gains life-saving medical insights by analysing human excrement. Ширкат як қатор се патентро пешниҳод кардааст, ки унсурҳои сенсори ҳоҷатхонаи тиббии худро фаро мегиранд.

Three Toilets Detection Health Technologies
The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Аврупо, Япония ва Хитой.
A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, Технологияи OutSense метавонад манбаи хунро дар роҳи меъдаю рӯда муайян кунад.
A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

Ба гуфтаи директори OutSense Йфат Ссиалом, who predicts that “бо таркиши тибби рақамӣ, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, бемориҳои илтиҳобии рӯда ва сироятҳои роҳҳои пешоб.
Its solution consists of a multispectral optical sensor, як манбаи рӯшноӣ ва дастгоҳи мустақили скрининг, ки пайвасти WiFi-ро дар бар мегирад. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.
OutSense has developed tools to diagnose abnormalities in human excreta. Маълумоте, ки аз хуни гирифташуда гирифта шудааст, якҷоя бо таҳлили иловагии вақт аз хунравӣ то ихроҷ, тафсилоти патологияи хунравӣ медиҳад. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.
At the beginning of June, OutSense эълон кард, ки CommuniCare, як ширкати бузурги тандурустӣ бо зиёда аз 90 healthcare facilities in the US, имсол ба тачрибавии технологияи худ шуруъ мекунад. Ба гайр аз ин лётчик, OutSense also plans to conduct clinical trials in Israel and Japan.

Ба Ахбори бештар нигаред News Viga.cc
Таъминкунандаи Фабрикаи iVIGA Tap